Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma
- Author
- RAMBALDI, Alessandro; LAZZARI, Manuela; GAMBA, Enrica; GARGANTINI, Livio; GATTEI, Valter; LAURIA, Francesco; LAZZARINO, Mario; MANDELLI, Franco; MORRA, Enrica; PULSONI, Alessandro; RIBERSANI, Michela; ROSSI-FERRINI, Pier Luigi; MANZONI, Cristina; RUPOLO, Maurizio; TURA, Sante; ZAGONEL, Vittorina; ZAJA, Francesco; ZINZANI, Pierluigi; REATO, Gigliola; FOA, Robin; CARLOTTI, Emanuela; ARCAINI, Luca; BACCARANI, Michele; BARBUI, Tiziano; BERNASCONI, Carlo; DASTOLI, Giuseppe; FUGA, Giovanna
Cattedra di Ematologia Università di Firenze, Italy
Cattedra di Ematologia Università di Pavia, Italy
Cattedra di Ematologia Università di Siena, Italy
Cattedra di Ematologia Università di Udine, Italy
Dipartimento di Biotecnologie Cellulari ed Ematologia, Università 'La Sapienza', Rome, Italy
Dipartimento di Scienze Biomediche ed Oncologia Umana, Università di Torino, Italy
Divisione di Ematologia Ospedale Niguarda Milano, Italy
Divisione di Ematologia, Ospedali Riuniti Bergamo, Italy
Istituto di Ematologia e Oncologia Medica Seragnoli, Università di Bologna, Italy
Oncologia Medica B e Nucleo di Ricerca Clinica e Laboratoristica in Ematologia, Centro di Riferimento Oncologico IRCCS Aviano, Italy
Roche SpA, Monza, Italy - Source
Blood. 2002, Vol 99, Num 3, pp 856-862 ; ref : 43 ref
- ISSN
- 0006-4971
- Scientific domain
- Medical oncology; Hematology
- Publisher
- The Americain Society of Hematology, Washington, DC
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Anticorps monoclonal Association médicamenteuse Chaîne peptidique lourde Chimiothérapie Gène hybride Gène onc cellulaire Homme Immunoglobuline Immunothérapie Lymphome folliculaire Maladie résiduelle imperceptible Protooncogène Rituximab Réaction chaîne polymérase Surveillance biologique Traitement Antigène CD20 Gène bcl2 Protocole CHOP Biologie moléculaire Génétique Hémopathie maligne Lymphome non hodgkinien Lymphoprolifératif syndrome
- Keyword (en)
- Antineoplastic agent Monoclonal antibody Drug combination Heavy peptide chain Chemotherapy Hybrid gene C-Onc gene Human Immunoglobulins Immunotherapy Follicular lymphoma Minimal residual disease Protooncogene Rituximab Polymerase chain reaction Biological monitoring Treatment Molecular biology Genetics Malignant hemopathy Non Hodgkin lymphoma Lymphoproliferative syndrome
- Keyword (es)
- Anticanceroso Anticuerpo monoclonal Asociación medicamentosa Cadena peptídica pesada Quimioterapia Gen híbrido Gen onc celular Hombre Inmunoglobulina Inmunoterapia Linfoma folicular Enfermedad residual imperceptible Protooncogen Rituximab Reacción cadena polimerasa Vigilancia biológica Tratamiento Biología molecular Genética Hemopatía maligna Linfoma no Hodgkin Linfoproliferativo síndrome
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
- Discipline
- Blood diseases
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 13454909
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1182/blood.V99.3.856 
https://dx.doi.org/10.1182/blood.V99.3.856
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1182\/blood.V99.3.856\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:121:\"Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"856\";s:8:\"\u0000*\u0000epage\";s:3:\"862\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"RAMBALDI\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Alessandro\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:26:{i:0;s:16:\"LAZZARI, Manuela\";i:1;s:13:\"GAMBA, Enrica\";i:2;s:17:\"GARGANTINI, Livio\";i:3;s:14:\"GATTEI, Valter\";i:4;s:17:\"LAURIA, Francesco\";i:5;s:16:\"LAZZARINO, Mario\";i:6;s:16:\"MANDELLI, Franco\";i:7;s:13:\"MORRA, Enrica\";i:8;s:19:\"PULSONI, Alessandro\";i:9;s:18:\"RIBERSANI, Michela\";i:10;s:25:\"ROSSI-FERRINI, Pier Luigi\";i:11;s:17:\"MANZONI, Cristina\";i:12;s:16:\"RUPOLO, Maurizio\";i:13;s:11:\"TURA, Sante\";i:14;s:18:\"ZAGONEL, Vittorina\";i:15;s:15:\"ZAJA, Francesco\";i:16;s:18:\"ZINZANI, Pierluigi\";i:17;s:15:\"REATO, Gigliola\";i:18;s:10:\"FOA, Robin\";i:19;s:18:\"CARLOTTI, Emanuela\";i:20;s:13:\"ARCAINI, Luca\";i:21;s:18:\"BACCARANI, Michele\";i:22;s:15:\"BARBUI, Tiziano\";i:23;s:17:\"BERNASCONI, Carlo\";i:24;s:17:\"DASTOLI, Giuseppe\";i:25;s:14:\"FUGA, Giovanna\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:121:\"Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1182\/blood.V99.3.856\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:121:\"Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"856\";s:8:\"\u0000*\u0000epage\";s:3:\"862\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"RAMBALDI\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Alessandro\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:26:{i:0;s:16:\"LAZZARI, Manuela\";i:1;s:13:\"GAMBA, Enrica\";i:2;s:17:\"GARGANTINI, Livio\";i:3;s:14:\"GATTEI, Valter\";i:4;s:17:\"LAURIA, Francesco\";i:5;s:16:\"LAZZARINO, Mario\";i:6;s:16:\"MANDELLI, Franco\";i:7;s:13:\"MORRA, Enrica\";i:8;s:19:\"PULSONI, Alessandro\";i:9;s:18:\"RIBERSANI, Michela\";i:10;s:25:\"ROSSI-FERRINI, Pier Luigi\";i:11;s:17:\"MANZONI, Cristina\";i:12;s:16:\"RUPOLO, Maurizio\";i:13;s:11:\"TURA, Sante\";i:14;s:18:\"ZAGONEL, Vittorina\";i:15;s:15:\"ZAJA, Francesco\";i:16;s:18:\"ZINZANI, Pierluigi\";i:17;s:15:\"REATO, Gigliola\";i:18;s:10:\"FOA, Robin\";i:19;s:18:\"CARLOTTI, Emanuela\";i:20;s:13:\"ARCAINI, Luca\";i:21;s:18:\"BACCARANI, Michele\";i:22;s:15:\"BARBUI, Tiziano\";i:23;s:17:\"BERNASCONI, Carlo\";i:24;s:17:\"DASTOLI, Giuseppe\";i:25;s:14:\"FUGA, Giovanna\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:121:\"Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:23:\"10.1182\/blood.V99.3.856\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1182\/blood.V99.3.856\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:121:\"Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"856\";s:8:\"\u0000*\u0000epage\";s:3:\"862\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"RAMBALDI\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Alessandro\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:26:{i:0;s:16:\"LAZZARI, Manuela\";i:1;s:13:\"GAMBA, Enrica\";i:2;s:17:\"GARGANTINI, Livio\";i:3;s:14:\"GATTEI, Valter\";i:4;s:17:\"LAURIA, Francesco\";i:5;s:16:\"LAZZARINO, Mario\";i:6;s:16:\"MANDELLI, Franco\";i:7;s:13:\"MORRA, Enrica\";i:8;s:19:\"PULSONI, Alessandro\";i:9;s:18:\"RIBERSANI, Michela\";i:10;s:25:\"ROSSI-FERRINI, Pier Luigi\";i:11;s:17:\"MANZONI, Cristina\";i:12;s:16:\"RUPOLO, Maurizio\";i:13;s:11:\"TURA, Sante\";i:14;s:18:\"ZAGONEL, Vittorina\";i:15;s:15:\"ZAJA, Francesco\";i:16;s:18:\"ZINZANI, Pierluigi\";i:17;s:15:\"REATO, Gigliola\";i:18;s:10:\"FOA, Robin\";i:19;s:18:\"CARLOTTI, Emanuela\";i:20;s:13:\"ARCAINI, Luca\";i:21;s:18:\"BACCARANI, Michele\";i:22;s:15:\"BARBUI, Tiziano\";i:23;s:17:\"BERNASCONI, Carlo\";i:24;s:17:\"DASTOLI, Giuseppe\";i:25;s:14:\"FUGA, Giovanna\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:121:\"Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1182\/blood.V99.3.856\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:121:\"Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"856\";s:8:\"\u0000*\u0000epage\";s:3:\"862\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"RAMBALDI\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Alessandro\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:26:{i:0;s:16:\"LAZZARI, Manuela\";i:1;s:13:\"GAMBA, Enrica\";i:2;s:17:\"GARGANTINI, Livio\";i:3;s:14:\"GATTEI, Valter\";i:4;s:17:\"LAURIA, Francesco\";i:5;s:16:\"LAZZARINO, Mario\";i:6;s:16:\"MANDELLI, Franco\";i:7;s:13:\"MORRA, Enrica\";i:8;s:19:\"PULSONI, Alessandro\";i:9;s:18:\"RIBERSANI, Michela\";i:10;s:25:\"ROSSI-FERRINI, Pier Luigi\";i:11;s:17:\"MANZONI, Cristina\";i:12;s:16:\"RUPOLO, Maurizio\";i:13;s:11:\"TURA, Sante\";i:14;s:18:\"ZAGONEL, Vittorina\";i:15;s:15:\"ZAJA, Francesco\";i:16;s:18:\"ZINZANI, Pierluigi\";i:17;s:15:\"REATO, Gigliola\";i:18;s:10:\"FOA, Robin\";i:19;s:18:\"CARLOTTI, Emanuela\";i:20;s:13:\"ARCAINI, Luca\";i:21;s:18:\"BACCARANI, Michele\";i:22;s:15:\"BARBUI, Tiziano\";i:23;s:17:\"BERNASCONI, Carlo\";i:24;s:17:\"DASTOLI, Giuseppe\";i:25;s:14:\"FUGA, Giovanna\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:121:\"Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1182\/blood.V99.3.856\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:121:\"Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"856\";s:8:\"\u0000*\u0000epage\";s:3:\"862\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"RAMBALDI\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Alessandro\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:26:{i:0;s:16:\"LAZZARI, Manuela\";i:1;s:13:\"GAMBA, Enrica\";i:2;s:17:\"GARGANTINI, Livio\";i:3;s:14:\"GATTEI, Valter\";i:4;s:17:\"LAURIA, Francesco\";i:5;s:16:\"LAZZARINO, Mario\";i:6;s:16:\"MANDELLI, Franco\";i:7;s:13:\"MORRA, Enrica\";i:8;s:19:\"PULSONI, Alessandro\";i:9;s:18:\"RIBERSANI, Michela\";i:10;s:25:\"ROSSI-FERRINI, Pier Luigi\";i:11;s:17:\"MANZONI, Cristina\";i:12;s:16:\"RUPOLO, Maurizio\";i:13;s:11:\"TURA, Sante\";i:14;s:18:\"ZAGONEL, Vittorina\";i:15;s:15:\"ZAJA, Francesco\";i:16;s:18:\"ZINZANI, Pierluigi\";i:17;s:15:\"REATO, Gigliola\";i:18;s:10:\"FOA, Robin\";i:19;s:18:\"CARLOTTI, Emanuela\";i:20;s:13:\"ARCAINI, Luca\";i:21;s:18:\"BACCARANI, Michele\";i:22;s:15:\"BARBUI, Tiziano\";i:23;s:17:\"BERNASCONI, Carlo\";i:24;s:17:\"DASTOLI, Giuseppe\";i:25;s:14:\"FUGA, Giovanna\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:121:\"Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
